Clinical Research Project - Compensated
Participate in a Paid Research Study To Understand Your Experience with GLP-1 Medications
Are you an adult in the US currently using an FDA-approved GLP-1 medication for weight management? You may be eligible to participate in a research study.
Bridge Access Solutions (BAS) is conducting a research study with individuals currently prescribed a GLP-1 medication to gain insight into real-world participant experiences and to identify unmet needs.
- What’s Involved: Completion of an electronic, 8–10-minute daily diary over a period of 6 weeks. You will be asked questions about your experience with GI symptoms (nausea, vomiting, diarrhea) and food/appetite, relative to your weekly GLP-1 dose.
- Eligibility: 18+ US adults with a BMI of 30 or greater (when you started treatment), currently using a GLP-1 medication without diabetes.
- Compensation: $125 upon study completion.
- When: Enrollment begins mid-March 2026.
- Privacy: Your feedback will be de-identified, and reasonable steps will be taken to protect your privacy. If you qualify and choose to participate, you may be asked to authorize access to relevant medical records.
If you are interested, complete our online screener, scan the QR code or visit:
https://20250159GLP1.studyenrollment.com/
This is not a clinical trial and does not involve medical treatment or advice. Your GLP-1 medication will not change, nor will a different medication be provided as part of your participation in this study. The cost of your GLP-1 medication will not be covered through your participation in this study.
Questions?
Call or text: (385) 786-6831
